A Disintegrin and Metalloprotease 10 Expressions Modulate Potential Metastatic and Thrombus Formation in Pancreatic Carcinoma
Background: Clinical investigations repurposing a disintegrin and metalloproteases 10 (ADAM10) as metastatic and thrombus marker have achieved encouraging results, but the mechanism behind this association remains unclear. Methods: This study was carried out in NingXia and Wuhan, China from 2017...
Main Authors: | Miao Yu, Quan Chen, Qin Li, Yunfei Teng, Lin Xiao, Guang Yang, Chenxi Ouyang, Ahmed Mohammed Elamin Abdalla |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2022-08-01
|
Series: | Iranian Journal of Public Health |
Subjects: | |
Online Access: | https://ijph.tums.ac.ir/index.php/ijph/article/view/27670 |
Similar Items
-
Novel Approaches and Challenges of Discovery of Exosite Modulators of a Disintegrin and Metalloprotease 10
by: Dmitriy Minond, et al.
Published: (2020-05-01) -
A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions
by: Nives Giebeler, et al.
Published: (2016-04-01) -
Nasal Delivery of D-Penicillamine Hydrogel Upregulates a Disintegrin and Metalloprotease 10 Expression via Melatonin Receptor 1 in Alzheimer’s Disease Models
by: Manli Zhong, et al.
Published: (2021-04-01) -
Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
by: Alexandra L. Matthews, et al.
Published: (2017-05-01) -
Expression of a disintegrin and metalloprotease 8 and endostatin in human osteosarcoma: Implication in tumor progression and prognosis
by: Dalia M. Abd El-Rehim, et al.
Published: (2015-03-01)